Data as of Jan 27
| +0.14 / +3.00%|
The 1 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +45.53% increase from the last price of 4.81.
The current consensus among 2 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.